4YD Stock Overview
A nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science applications worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Nanologica AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.17 |
| 52 Week High | SEK 0.94 |
| 52 Week Low | SEK 0.17 |
| Beta | 0.39 |
| 11 Month Change | 6.06% |
| 3 Month Change | -58.53% |
| 1 Year Change | -81.22% |
| 33 Year Change | -84.78% |
| 5 Year Change | n/a |
| Change since IPO | -89.13% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4YD | DE Biotechs | DE Market | |
|---|---|---|---|
| 7D | -10.3% | -0.4% | -1.8% |
| 1Y | -81.2% | -15.4% | 13.6% |
Return vs Industry: 4YD underperformed the German Biotechs industry which returned -15.4% over the past year.
Return vs Market: 4YD underperformed the German Market which returned 13.6% over the past year.
Price Volatility
| 4YD volatility | |
|---|---|
| 4YD Average Weekly Movement | 18.8% |
| Biotechs Industry Average Movement | 6.1% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 11.5% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 4YD's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 4YD's weekly volatility has increased from 12% to 19% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 16 | Andreas Bhagwani | www.nanologica.com |
Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science applications worldwide. The company operates through two segments, Drug Development and Chromatography. It offers NLAB Saga, a new generation silica for preparative chromatography; and SVEA HPLC analytical columns.
Nanologica AB (publ) Fundamentals Summary
| 4YD fundamental statistics | |
|---|---|
| Market cap | €8.89m |
| Earnings (TTM) | -€6.56m |
| Revenue (TTM) | €730.22k |
12.2x
P/S Ratio-1.4x
P/E RatioIs 4YD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4YD income statement (TTM) | |
|---|---|
| Revenue | SEK 8.50m |
| Cost of Revenue | SEK 5.06m |
| Gross Profit | SEK 3.44m |
| Other Expenses | SEK 79.72m |
| Earnings | -SEK 76.29m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 07, 2025
| Earnings per share (EPS) | -1.73 |
| Gross Margin | 40.44% |
| Net Profit Margin | -898.03% |
| Debt/Equity Ratio | 419.8% |
How did 4YD perform over the long term?
See historical performance and comparison